e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Quality, performance and interpretation of lung function testing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
DLCO biological controls in clinical practice.
G. Roque Guerin (Barcelona, Spain), M. Palomo (Barcelona, Spain), M. Medina (Barcelona, Spain), J. Moises (Barcelona, Spain), F. Burgos (Barcelona, Spain)
Source:
International Congress 2019 – Quality, performance and interpretation of lung function testing
Session:
Quality, performance and interpretation of lung function testing
Session type:
Thematic Poster
Number:
1132
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Roque Guerin (Barcelona, Spain), M. Palomo (Barcelona, Spain), M. Medina (Barcelona, Spain), J. Moises (Barcelona, Spain), F. Burgos (Barcelona, Spain). DLCO biological controls in clinical practice.. 1132
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Verification of flow rate stability in high-flow nasal cannula devices
Cardiopulmonary exercise testing: can you trust the data
Related content which might interest you:
A correlative analysis between spirometry and MostGraph using the 23306 data from 3979 patients in clinical practice.
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
DLco simulations for qualification of DLco devices globally for inhaled levodopa clinical trials.
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019
Interpreting lung function in clinical practice
Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease
Year: 2006
Pattern of diffusion disturbance related to clinical diagnosis: the K
CO
has no additional diagnostic value next to the DL
CO
Source: Eur Respir J 2005; 26: Suppl. 49, 523s
Year: 2005
Reducing the variability of DLCO measurements in clinical trials
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
The better explanation of COPD: the clinical role of FVC grouping
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
A critical evaluation of the relevance of different asthma phenotypes for clinical practice
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
Correlations of ventilation heterogeneity and spirometry in asthma; initial experience with hyperpolarised gas MRI in a clinical setting.
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019
An international survey on genetics in clinical practice for interstitial lung disease.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Association of demographic, laboratory and clinical parameters with HRCT-chest findings in patients with sarcoidosis.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
COPD management in Swedish clinical practice
Source: Annual Congress 2007 - Primary care management of COPD
Year: 2007
Assessment of disease control in smokers and non-smokers with asthma in Switzerland: results of an experience-based report in medical practice
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
The clinical usefulness of spirometric information
Source: Breathe 2008; 5: 214-220
Year: 2009
ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021
Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010
FEV
6
: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept